NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Takeda Pharmaceutical Company Limited (PINK: TKPHF)
TKPHF Technical Analysis
3
As on 4th Apr 2025 TKPHF STOCK Price closed @ 30.07 and we RECOMMEND Sell for LONG-TERM with Stoploss of 30.83 & Sell for SHORT-TERM with Stoploss of 31.22 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TKPHFSTOCK Price
Open | 30.08 | Change | Price | % |
High | 30.08 | 1 Day | 3.31 | 12.37 |
Low | 30.07 | 1 Week | 3.07 | 11.37 |
Close | 30.07 | 1 Month | 0.07 | 0.23 |
Volume | 230000 | 1 Year | 1.10 | 3.80 |
52 Week High 34.47 | 52 Week Low 24.48 |
PINK USA Most Active Stocks
PSWW | 0.00 | % |
TXGE | 3316.21 | 2.69% |
CYBL | 0.01 | % |
DRNK | 0.00 | % |
AFFU | 0.00 | % |
HCMC | 0.00 | % |
APLD | 10.07 | -2.99% |
VNUE | 0.00 | % |
HYSR | 0.04 | 0.00% |
ITOX | 0.00 | % |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
TKPHF Daily Charts |
TKPHF Intraday Charts |
Whats New @ Bazaartrend |
TKPHF Free Analysis |
|
TKPHF Important Levels Intraday
RESISTANCE | 30.09 |
RESISTANCE | 30.08 |
RESISTANCE | 30.08 |
RESISTANCE | 30.08 |
SUPPORT | 30.06 |
SUPPORT | 30.06 |
SUPPORT | 30.06 |
SUPPORT | 30.05 |
TKPHF Forecast July 2025
4th UP Forecast | 37.07 |
3rd UP Forecast | 34.82 |
2nd UP Forecast | 33.44 |
1st UP Forecast | 32.05 |
1st DOWN Forecast | 28.09 |
2nd DOWN Forecast | 26.7 |
3rd DOWN Forecast | 25.32 |
4th DOWN Forecast | 23.07 |
TKPHF Weekly Forecast
4th UP Forecast | 33.06 |
3rd UP Forecast | 32.10 |
2nd UP Forecast | 31.51 |
1st UP Forecast | 30.91 |
1st DOWN Forecast | 29.23 |
2nd DOWN Forecast | 28.63 |
3rd DOWN Forecast | 28.04 |
4th DOWN Forecast | 27.08 |
TKPHF Forecast2025
4th UP Forecast | 50.63 |
3rd UP Forecast | 44.04 |
2nd UP Forecast | 39.96 |
1st UP Forecast | 35.89 |
1st DOWN Forecast | 24.25 |
2nd DOWN Forecast | 20.18 |
3rd DOWN Forecast | 16.1 |
4th DOWN Forecast | 9.51 |
Takeda Pharmaceutical Company Limited ( PINK USA Symbol : TKPHF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TKPHF Other Details
Segment | EQ | |
Market Capital | 44211683328.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
TKPHF Address
![]() |
TKPHF Latest News
TKPHF Business Profile
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, marketing, and out-licensing of pharmaceutical products worldwide. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the Entyvio, Gattex/Revestive, Alofisel, Natpara, Adynovate/Adynovi, Takhzyro, Elaprase, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Albumin/Flexbumin, Ninlaro, and Alunbrig brands. Takeda Pharmaceutical Company has licensing agreements with Denali Therapeutics and Wave Life Sciences Ltd; collaboration agreements with Neurocrine Biosciences, Inc. and Rani Therapeutics LLC; license and research agreements with The University of Texas MD Anderson Cancer Center, Poseida Therapeutics, Inc., and Arrowhead Pharmaceuticals Inc.; research collaboration agreements with Arrowhead Pharmaceuticals Inc. and Ovid Therapeutics Inc.; and collaboration with Evox Therapeutics Ltd., as well as a licensing agreement with ProThera Biologics Inc. It also has strategic alliances with Egle Therapeutics SAS; Evotec SE; Neurocrine Biosciences, Inc.; Carmine Therapeutics; HemoShear Therapeutics, LLC; KSQ Therapeutics; and Anima Biotech. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Address: 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service